Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/120579
Title: EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
Authors: TEO YI LING
Keywords: Pharmacokinetics, tyrosine kinase inhibitors, sunitinib, lapatinib, toxicities, drug-drug interactions
Issue Date: 3-Mar-2015
Citation: TEO YI LING (2015-03-03). EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES. ScholarBank@NUS Repository.
Abstract: The advent of molecular targeted therapy in the late 1990s marks a major breakthrough in the fight against cancer. While the use of tyrosine kinase inhibitors (TKIs) have largely mitigated the conventional toxicities of chemotherapeutic agents, a range of previously unknown and sometimes unpredictable toxicities like cutaneous, cardiac and liver toxicities began to surface. Furthermore, several new issues such as the tailoring of cancer treatment to an individual patient, assessing patient adherence to therapy and evaluating drug effectiveness and toxicity are raised with these novel targeted therapies. Therefore, the overall aim of this thesis is to evaluate how pharmacokinetic alterations in TKIs can contribute to toxicities, by focusing on three main themes of drug exposure, genetic polymorphism and drug-drug interactions. It is important that these issues with toxicities are addressed to improve the management of anticancer therapy in patients so as to optimize risk/benefit ratio of these therapies.
URI: http://scholarbank.nus.edu.sg/handle/10635/120579
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
TeoYL.pdf1.81 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

219
checked on Nov 24, 2022

Download(s)

223
checked on Nov 24, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.